4//SEC Filing
VERTEX PHARMACEUTICALS INC / MA 4
Accession 0000875320-08-000028
$VRTXCIK 0000875320operating
Filed
May 20, 8:00 PM ET
Accepted
May 21, 3:38 PM ET
Size
19.2 KB
Accession
0000875320-08-000028
Insider Transaction Report
Form 4
BRIMBLECOMBE ROGER W
Director
Transactions
- Sale
Common Stock
2008-05-20$27.50/sh−334$9,185→ 2,999 total - Sale
Common Stock
2008-05-20$27.47/sh−667$18,322→ 333 total - Sale
Common Stock
2008-05-20$27.71/sh−667$18,483→ 1,333 total - Sale
Common Stock
2008-05-20$27.58/sh−333$9,184→ 2,666 total - Exercise/Conversion
Common Stock
2008-05-20$14.20/sh+3,333$47,329→ 3,333 total - Award
Stock Option
2008-05-20−3,333→ 3,333 totalExercise: $14.20From: 1998-09-01Exp: 2008-05-31→ Common Stock (3,333 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to Dr. Brimblecombe's company approved sales plan established under Rule 10b5-1.
- [F2]Right to buy under 1996 Stock and Option Plan, fully vested on grant date, 6/1/1998.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0000875320
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 3:38 PM ET
- Size
- 19.2 KB